Bittium Corporation's subsidiary Bittium Biosignals Ltd and Preventice Solutions have signed an extension agreement for the supply of ECG monitoring devices
Stock Exchange Release Free for publication on February 2, 2022, at 8.30 am (CET+1) Bittium Corporation's subsidiary Bittium Biosignals Ltd and Preventice Solutions have signed an extension agreement for the supply of ECG monitoring devices Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and Preventice Solutions, a wholly owned subsidiary of Boston Scientific, have today signed an agreement by which Bittium will extend its supply of BodyGuardian® MINI devices for monitoring cardiac arrhythmias to Preventice Solutions. In addition, according to the agreement the parties